Targeted therapy (TKI) cost for kidney cancer — what one month on the tablet actually adds up to
Ask what targeted therapy for kidney cancer costs per month and the honest answer is that it depends on four things — which drug within the class you are prescribed, the strength and how many tablets a day, whether the schedule runs continuously or in weeks on and weeks off, and whether you are dispensed the originator brand or an Indian-made version. We do not publish a monthly price we cannot stand behind for your case. What this page does instead is show you exactly how the figure is built, what else is billed alongside the tablet, and which funding routes are worth checking before you buy the first month.
- The tablet is most of the month, not all of it — Around it sit the bloods, a clinic review, supportive medicines and a scan at intervals. Costing only the strip is how people get caught out.
- Strength and schedule move the number — Dose reductions are a normal part of this class, not a failure, and they usually change what you spend that month.
- Check the funding route first — ArogyaSri, CGHS and cashless insurance are accepted at CION. What a scheme covers for a medicine taken at home is a separate question from what it covers for a day-care infusion.
- In-house, and written down before you start — Targeted therapy, immunotherapy, radiation, bloods and CT scans are delivered by our own team. Surgery, ablation and PET-CT are coordinated with specialist partner centres and billed there.
on Panel
Telangana & AP
Treated
(800+ reviews)
What a month of targeted therapy is actually made of
Most people price the strip of tablets and stop there. The bill for a month has five other lines in it, and knowing which ones move is what lets you plan instead of guess. If you want the mechanism first — what the tablet blocks and why kidney cancer responds to it — read targeted therapy (TKIs) for kidney cancer. For the wider picture across surgery, systemic therapy and scans, see kidney cancer treatment cost in Hyderabad.
| What is billed | What it is | What moves it up or down |
|---|---|---|
| The tablet | The targeted drug itself — usually a VEGF TKI, sometimes an mTOR inhibitor — dispensed as a month’s supply and taken at home. | Which drug within the class, the prescribed strength, tablets per day, continuous versus weeks-on/weeks-off dosing, and whether the originator brand or an Indian-made version is dispensed. |
| Monitoring bloods | Blood counts, kidney and liver function, and thyroid checks — done in-house at CION. | Frequent in the first weeks while the dose is being settled, then usually spaced out once you are stable. |
| Clinic review | The consultation itself — 45 minutes at CION, with blood pressure checked every visit because a rise is expected with this class. | How often you are being seen. The first consultation is free, and reviews typically become less frequent as the months settle. |
| Response scans | A CT at intervals to see whether the disease is being held. Diagnosis and follow-up imaging of this kind is delivered in-house. | The interval your oncologist sets. Where a PET-CT is specifically asked for, that is coordinated with a specialist partner imaging centre and billed there, not by us. |
| Supportive medicines | Whatever is needed to keep you comfortable — most often a blood-pressure tablet, sometimes mouth care, thyroid replacement or something for loose motions. | Largely dose-related. Some months there is nothing on this line at all; in others it is what keeps you on treatment. |
| One-off, not monthly | The staging and pathology work done before treatment starts, and any procedure already completed. | This is why the first month usually looks bigger than the ones that follow. Ask for the recurring monthly figure separately from the start-up figure. |
We do not publish a rupee figure for this class, because a number quoted without your prescription in front of us would be a guess dressed up as information. The strength, the schedule and the form dispensed change it too much. What we will do is cost your own month line by line and give it to you in writing, along with what would change it later — ask for it at the first visit, or request a written cost estimate now. Named regimens and how they are funded sit on our kidney cancer treatment in Hyderabad page, and the whole disease is covered in our kidney cancer guide.
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Dr. Mohammed Imran
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Know the monthly figure before you start, not after
Bring the prescription and your scheme or policy card. We will cost the month line by line, check what is covered, and put both in writing. Decisions for healing, not billing.
Five steps to a monthly figure you can plan around
Do these in order and you will leave the first visit with a figure rather than a range you have to keep re-checking. Every step is something you can ask for out loud — none of it is a favour.
Start with the written prescription, not the drug’s reputation
A pharmacy prices a strength and a quantity, not a headline. Bring the prescription itself and make sure it states the drug, the strength, how many a day and the schedule — continuous, or a set number of weeks on followed by weeks off. Two people on the same class of tablet can have very different monthly bills purely because of those three lines.
Ask which form is being dispensed, and why
For several tablets in this class, an Indian-made version exists alongside the originator brand, and the difference in price between them can be substantial. Which is appropriate for you is a clinical decision, not a shopping one — ask your oncologist directly what is being dispensed and what the reasoning is. It is a normal question here and it will not offend anyone.
Add the month around the tablet
Ask for the bloods, the review, the supportive medicines and the scan interval to be costed with it, so nothing arrives as a surprise in week three. At CION those are done in-house by the same team, which is what makes a single written estimate possible. If a PET-CT is being requested, ask for that separately — it is coordinated with a specialist partner centre and billed there.
Check the funding route before the first purchase
ArogyaSri, CGHS and cashless insurance are accepted at CION; in Andhra Pradesh the state scheme people ask about is NTR Vaidya Seva. Cover for a medicine you take at home is decided differently from cover for a day-care infusion, so ask specifically about the tablet. Bring the policy or scheme card to the first visit — checking it afterwards is what leaves people out of pocket.
Get it in writing, then plan for the long run
Ask for two numbers: the start-up month, which carries the baseline tests, and the settled monthly figure that follows. Ask what would change either — a dose reduction, a scan interval, a switch of class. The treatment plan itself is built along NCCN lines and reviewed by a tumour board, and the costing should be just as explicit. Request a written cost estimate if nobody has offered you one.
Six things that change what a month costs
Five of these are worth pulling. The last one is the trade people make quietly, on their own, and it is the one that costs the most in the end.
The scheme check is worth doing first
ArogyaSri, CGHS and cashless insurance are accepted at CION, and NTR Vaidya Seva is the equivalent state scheme in Andhra Pradesh. What each covers for an oral cancer drug differs from what it covers for an infusion. Our counselling desk checks yours and writes down what is covered before you buy month one.
Brand and Indian-made are a real conversation
For several tablets in this class both exist, and the gap between them is not small. It is a clinical decision rather than a purely financial one, so raise it with your oncologist rather than at the pharmacy counter. Ask what is being dispensed, and what the reasoning behind that choice is.
A dose reduction usually lowers the spend
Effects with this class are largely dose-related, so easing the dose is a standard way of keeping you comfortable and on treatment — not a sign of failure. A lower strength or fewer tablets generally means a smaller monthly outgoing. That decision belongs to your oncologist, never to the household budget alone.
A tablet alone and a tablet with an infusion are different budgets
In advanced clear cell disease a targeted tablet is often paired with a PD-1 inhibitor given in day care, which adds a per-cycle cost with its own rhythm. If more than one route is reasonable in your case, ask for both costed side by side — then choose on clinical grounds, with the money visible rather than hidden.
The first month is the heaviest
Baseline tests, close review and the staging work sit at the front. Once the dose has settled, bloods and reviews are usually spaced out and scans move to longer intervals. Ask at each review whether the schedule can be widened — sometimes it safely can, and that is a legitimate saving.
Never save money by skipping the bloods or halving the dose
The monitoring is what catches a rising blood pressure or a thyroid change early, and it is the reason people stay on treatment comfortably. Cutting doses quietly can cost you the control the tablet exists to give. If cost is the reason you are considering it, say so at the next review — it is a common conversation and there is usually something we can do.
Where the money and the medicine meet. The plan itself is built along NCCN lines and reviewed by a tumour board rather than by one doctor, and cost is never the reason a class is chosen or dropped. At CION the systemic treatment — targeted, immunotherapy and mTOR-directed — along with radiation, diagnosis, bloods, CT imaging and survivorship care is delivered in-house by our own team, so a single written estimate can cover the whole month. Nephrectomy, ablation and PET-CT are coordinated with specialist urology, uro-oncology and interventional radiology partners, where they are billed separately — and we will tell you that up front rather than after the fact.
Transparent costs, explained by the doctor treating you
Forty-five minutes, in plain language, with the plan and the price written down. The first consultation is free and there is no commitment to start treatment.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.Questions people ask about the cost of targeted therapy
How much does targeted therapy for kidney cancer cost per month?
There is no single figure, and any page that gives you one without seeing your prescription is guessing. The monthly cost of a targeted tablet turns on four things: which drug within the class you have been prescribed, the strength and how many tablets a day, whether the schedule runs continuously or in weeks on and weeks off, and whether you are dispensed the originator brand or an Indian-made version. Around the tablet sit the monthly bloods, a clinic review, supportive medicines and a scan at intervals. What CION does instead of publishing a number is work out your own figure, line by line, and put it in writing before you start, including what would change it later.
What else is billed besides the tablet itself?
Four things, in most months. The bloods - blood counts, kidney and liver function and thyroid checks - which are frequent at the start and usually spaced out once you are settled. The clinic review, which at CION is a 45-minute consultation. Supportive medicines, most commonly a blood-pressure tablet, because raised blood pressure is an expected effect of this class rather than a surprise. And a response scan at intervals, usually a CT. Bloods, scans and reviews are done in-house by our own team. Where a PET-CT is asked for, that is coordinated with a specialist partner imaging centre and billed there. The staging and pathology work happens once, before treatment starts, which is why the first month usually looks bigger than the ones that follow.
Is targeted therapy cheaper than immunotherapy for kidney cancer?
They have different shapes rather than a simple ranking. A targeted tablet is a steady monthly outgoing that continues for as long as it is working. Immunotherapy is an infusion given in day care on a set rhythm, so it is billed per cycle, along with the visit and the bloods that go with it. Many people with advanced clear cell kidney cancer are offered both together, in which case you are budgeting for both. Cost is not the right way to choose between the two - tumour type, IMDC risk group, your other medical conditions and NCCN guidance decide that. If two routes are genuinely reasonable in your case, ask for an estimate for each, side by side, and decide with the whole picture in front of you.
Does Aarogyasri or health insurance cover targeted therapy tablets?
CION accepts Aarogyasri, CGHS and cashless insurance, and the state scheme people ask about in Andhra Pradesh is NTR Vaidya Seva. What a scheme or policy covers for a cancer medicine taken at home is a separate question from what it covers for a day-care infusion, and it varies by scheme, by policy and sometimes by the drug itself. The practical step is to bring the written prescription and your policy or scheme card to the first visit, so the cover is checked before you buy the first month rather than after it. Ask for three things in writing: what is covered, what is not, and what you will pay yourself.
Does a dose reduction lower the monthly cost?
Often yes, because less is being dispensed. Dose reductions are a normal part of treatment with this class - the effects are largely dose-related, so easing the dose is how the team keeps you comfortable and on treatment, and it is not a sign that anything has failed. If the lower dose means a lower strength or fewer tablets, the monthly spend usually falls with it. What you must never do is cut or skip doses yourself to save money. The dose is chosen to keep the pathway blocked, and quietly halving it can cost you the control the tablet is there to give. If cost is the reason you are thinking about it, say so - it is a common and fixable conversation.
How long will I be paying for targeted therapy?
There is no set number of cycles. A targeted tablet continues for as long as it is holding the disease and you are tolerating it, which for some people is a long stretch, so it is best planned as a running monthly cost rather than a course with an end date. The pattern usually settles: the first month carries the baseline tests, then reviews and bloods space out once you are stable, and scans come at intervals. If the disease progresses, or the tablet is not tolerated, the plan changes and so does the cost - and at CION that decision goes to a tumour board rather than to one doctor. It is fair to ask at each review whether the monitoring schedule can be spaced out.
This page is general information about how the cost of one class of kidney cancer medicine is built up. It is not a quotation, not a price list and not a prescription, and it cannot replace a specialist review of your own pathology, scans and blood results. Drug prices, scheme cover and insurance terms change, and what applies to you depends on the exact drug, strength and schedule prescribed. Only a doctor who has seen your reports can say whether targeted therapy is right for you. Never start, stop, reduce or skip a prescribed tablet because of cost without telling your team first — there is almost always a better option than doing it quietly. If you are already on treatment, report severe or bloody diarrhoea, chest pain, breathlessness, a severe headache or a very high blood-pressure reading the same day.